Literature DB >> 20932969

Aqueous humor rapidly stimulates myocilin secretion from human trabecular meshwork cells.

Zachary T Resch1, Cheryl R Hann, Kimberly A Cook, Michael P Fautsch.   

Abstract

Myocilin, a protein associated with the development of glaucoma, is expressed in most eye tissues with highest expression observed in trabecular meshwork cells. In culture, primary human trabecular meshwork cells incubated in 10% fetal bovine serum have reduced myocilin expression compared to in vivo, but incubation in human aqueous humor, their normal in vivo nutrient source, restores myocilin expression to near in vivo levels. To investigate the mechanism by which human aqueous humor stimulates myocilin accumulation in conditioned media from normal human trabecular meshwork cells, three independent trabecular meshwork cell lines were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing various supplements: fetal bovine serum (10%), human serum (0.2%), porcine aqueous humor (50%), bovine serum albumin (0.1%), dexamethasone (10(-7)M), human aqueous humor (50%) or heat-inactivated human aqueous humor (50%). Conditioned media from cultured primary trabecular meshwork cells following incubation in human aqueous humor showed significant accumulation of myocilin in a time- (15 min) and dose-dependent manner (half maximal effective concentration ∼ 30%) while intracellular myocilin levels decreased. Minimal myocilin accumulation was observed in conditioned media isolated from trabecular meshwork cells cultured in DMEM containing fetal bovine or human serum, bovine serum albumin, porcine aqueous humor, dexamethasone or DMEM alone. Heat inactivation of human aqueous humor nearly eliminated human aqueous humor-stimulated myocilin secretion. Inhibitors of new protein synthesis, gene transcription, the endoplasmic reticulum/Golgi system and endocytic/exocytic secretory pathways failed to inhibit human aqueous humor-stimulated myocilin secretion. Using immunolabeling and transmission electron microscopy, myocilin was found associated with 70-90 nm vesicle-like structures within the cytoplasm of human aqueous humor treated trabecular meshwork cells. These studies suggest that myocilin secretion from trabecular meshwork cells occurs in a Golgi-independent manner following human aqueous humor treatment. Heat-labile factors in human aqueous humor are responsible for the time- and dose-dependent release of myocilin from vesicle-like structures within the cytoplasm of trabecular meshwork cells. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932969      PMCID: PMC2993854          DOI: 10.1016/j.exer.2010.09.017

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  60 in total

1.  Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma.

Authors:  M F Adam; A Belmouden; P Binisti; A P Brézin; F Valtot; A Béchetoille; J C Dascotte; B Copin; L Gomez; A Chaventré; J F Bach; H J Garchon
Journal:  Hum Mol Genet       Date:  1997-11       Impact factor: 6.150

Review 2.  Endothelin and its potential role in glaucoma.

Authors:  Balwantray C Chauhan
Journal:  Can J Ophthalmol       Date:  2008-06       Impact factor: 1.882

3.  A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping.

Authors:  R Kubota; S Noda; Y Wang; S Minoshima; S Asakawa; J Kudoh; Y Mashima; Y Oguchi; N Shimizu
Journal:  Genomics       Date:  1997-05-01       Impact factor: 5.736

4.  Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin.

Authors:  J Ortego; J Escribano; M Coca-Prados
Journal:  FEBS Lett       Date:  1997-08-18       Impact factor: 4.124

5.  Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork.

Authors:  E Lütjen-Drecoll; C A May; J R Polansky; D H Johnson; H Bloemendal; T D Nguyen
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-03       Impact factor: 4.799

6.  Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure.

Authors:  Allan R Shepard; Nasreen Jacobson; J Cameron Millar; Iok-Hou Pang; H Thomas Steely; Charles C Searby; Val C Sheffield; Edwin M Stone; Abbot F Clark
Journal:  Hum Mol Genet       Date:  2007-02-22       Impact factor: 6.150

7.  Fibrillar islet amyloid polypeptide (amylin) is internalised by macrophages but resists proteolytic degradation.

Authors:  M K Badman; R A Pryce; S B Chargé; J F Morris; A Clark
Journal:  Cell Tissue Res       Date:  1998-02       Impact factor: 5.249

8.  CYP1B1 and MYOC mutations in 116 Chinese patients with primary congenital glaucoma.

Authors:  Yuhong Chen; Deke Jiang; Long Yu; Bradley Katz; Kang Zhang; Bo Wan; Xinghuai Sun
Journal:  Arch Ophthalmol       Date:  2008-10

9.  Aqueous humor myocilin protein levels in normal, genetic carriers, and glaucoma Beagles.

Authors:  E O Mackay; M E Källberg; K N Gelatt
Journal:  Vet Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.644

10.  Myocilin protein levels in the aqueous humor of the glaucomas in selected canine breeds.

Authors:  E O MacKay; M E Kallberg; K P Barrie; W Miller; J S Sapienza; H Denis; F J Ollivier; C Plummer; T Rinkoski; N Scotty; K N Gelatt
Journal:  Vet Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.644

View more
  16 in total

1.  Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells.

Authors:  Joshua T Morgan; Joshua A Wood; Naomi J Walker; Vijay Krishna Raghunathan; Dori L Borjesson; Christopher J Murphy; Paul Russell
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-23       Impact factor: 2.671

2.  Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex.

Authors:  Myung Kuk Joe; Changwon Kee; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2012-02-25       Impact factor: 5.157

3.  The stability of myocilin olfactomedin domain variants provides new insight into glaucoma as a protein misfolding disorder.

Authors:  J Nicole Burns; Katherine C Turnage; Chandler A Walker; Raquel L Lieberman
Journal:  Biochemistry       Date:  2011-06-09       Impact factor: 3.162

4.  Gene expression profile in human trabecular meshwork from patients with primary open-angle glaucoma.

Authors:  Yutao Liu; R Rand Allingham; Xuejun Qin; David Layfield; Andrew E Dellinger; Jason Gibson; Joshua Wheeler; Allison E Ashley-Koch; W Daniel Stamer; Michael A Hauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-27       Impact factor: 4.799

Review 5.  Major review: Molecular genetics of primary open-angle glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2017-05-10       Impact factor: 3.467

6.  Protein profile of exosomes from trabecular meshwork cells.

Authors:  W D Stamer; E A Hoffman; J M Luther; D L Hachey; K L Schey
Journal:  J Proteomics       Date:  2011-03-08       Impact factor: 4.044

7.  Amyloid fibril formation by the glaucoma-associated olfactomedin domain of myocilin.

Authors:  Susan D Orwig; Christopher W Perry; Laura Y Kim; Katherine C Turnage; Rong Zhang; Douglas Vollrath; Ingeborg Schmidt-Krey; Raquel L Lieberman
Journal:  J Mol Biol       Date:  2011-12-13       Impact factor: 5.469

Review 8.  Molecular genetics in glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2011-08-18       Impact factor: 3.467

Review 9.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

10.  Effects of transforming growth factor-β2 on myocilin expression and secretion in human primary cultured trabecular meshwork cells.

Authors:  Yuyu Wu; Wanzhu Chen; Maosheng Guo; Qin He; Yan Hu
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.